• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Latest News

Combination of Abrocitinib and Dupilumab Effectively Treats Pediatric Atopic Dermatitis
Combination of Abrocitinib and Dupilumab Effectively Treats Pediatric Atopic Dermatitis

October 17th 2024

With this combined administration, patients saw noticeable and lasting improvements in severe cases of AD.

Understanding the Role of Micronutrients in Vitiligo
Understanding the Role of Micronutrients in Vitiligo

October 17th 2024

Study Quantifies, Characterizes Health Care Burden of Prurigo Nodularis in England
Study Quantifies, Characterizes Health Care Burden of Prurigo Nodularis in England

October 17th 2024

A Holistic Approach to Assessing and Enhancing Skin Quality
A Holistic Approach to Assessing and Enhancing Skin Quality

October 17th 2024

Eyelashes: Hair Today, Gone Tomorrow
Eyelashes: Hair Today, Gone Tomorrow

October 17th 2024

Navigating CSU Diagnosis: Best Practices
Meet the 2024 Quarterly Editor in Chiefs
Subscribe Now for Free - eNL
Explore Our Conference Coverage
Subscribe for Free - Print
Stay Informed!
Don't miss the latest in dermatology news
2

Conference Coverage

View All
Conference Speaker Sneak Peek: Elevate-Derm
Conference Speaker Sneak Peek: Elevate-Derm

October 14th 2024

Highly Prevalent, Scarcely Supported: Common Skin Issues Remain Underserved
Highly Prevalent, Scarcely Supported: Common Skin Issues Remain Underserved

October 10th 2024

Phase 2b Trial Reinforces Zasocitinib’s Safety Profile
Phase 2b Trial Reinforces Zasocitinib’s Safety Profile

October 8th 2024

Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas
Tralokinumab Shows Long-Term Efficacy for AD in Sensitive Areas

October 7th 2024

Latest Videos

All News

© 2024 MJH Life Sciences

All rights reserved.